Intrauterine growth restriction: new standards for assessing adverse outcome

Area of Science:

• Perinatal Medicine
• Maternal-Fetal Medicine
• Neonatology

Background:

• Intrauterine growth restriction (IUGR) is associated with adverse perinatal outcomes.
• Conventional birthweight standards may fail to identify all cases of fetal growth restriction.
• Obesity in pregnancy is linked to increased perinatal mortality, potentially mediated by IUGR.

Purpose of the Study:

• To evaluate the utility of a customized birthweight standard in assessing the association between IUGR and adverse outcomes.
• To identify unrecognized fetal growth restriction and its impact on perinatal mortality risk, particularly in obese pregnancies.

Main Methods:

• Application of a birthweight standard based on customized growth potential.
• Retrospective quantification of the association between IUGR and adverse outcomes.
• Analysis of growth failure not identified by conventional standards.

Main Results:

• Customized growth potential standards effectively quantify the link between IUGR and adverse outcomes, regardless of antenatal identification.
• Growth failure in specific populations (e.g., large mothers with average-sized babies) was identified as IUGR.
• Unrecognized IUGR contributes to increased perinatal mortality risk in obese pregnancies.

Conclusions:

• A customized birthweight standard is beneficial for studying IUGR and its associations with adverse outcomes.
• Timely antenatal detection of fetal growth restriction is crucial for management and prevention of perinatal morbidity and mortality.
• IUGR is a significant factor in increased perinatal mortality risk, especially in obese pregnancies.